Cesca Therapeutics Inc.

Cesca Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
20.65 M
Public Float
4.61 M
Cesca Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$22.5
Market Cap
$7.92 M
Shares Outstanding
20.65 M
Public Float
4.61 M

Profile

Address
2711 Citrus Road
Rancho Cordova California 95742
United States
Employees -
Website http://www.cescatherapeutics.com
Updated 07/08/2019
Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets.

Financials

View All
Created with Highcharts 5.0.14Cesca Therapeutics Inc.Net Income. Fiscal year is July-June. All values USD Thousands.3 0863 0868 6318 63114 85214 85218 58818 58829 09529 09539 71639 716201320142015201620172018010k20k30k40k50k
Created with Highcharts 5.0.14Cesca Therapeutics Inc.Sales/Revenue. Fiscal year is July-June. All values USD Thousands.17 96317 96315 98715 98716 04216 04211 92911 92914 52514 5259 6729 67220132014201520162017201805k10k15k20k

Xiao Chun Xu
Chairman, President & Chief Executive Officer
Vivian H. Liu
Chief Operating Officer, Secretary & Director